Tooth Margaret sold $11K of TRUP

Tooth Margaret (CEO) sold 491 shares of TRUPANION, INC. (TRUP) at $21.86 on 2026-05-25.

Original reporting
SEC EDGAR · Tooth Margaret
Published May 28, 2026, 1:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 28, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

This is an ownership-change event: the CEO executed an open-market sale of 491 shares at a stated price, which may briefly affect sentiment but does not provide new operational or financial information.

02

Market read

Traders may monitor insider-flow for sentiment, but absent a fundamental catalyst, expected price reaction is typically muted.

03

What to watch

No 10b5-1 plan is cited, but the filing alone doesn’t reveal intent; without follow-on filings or operational news, trading impact should be discounted.

Relevance 6/10Timing: Immediate (today/next session) as traders may react to insider-flow headlines; otherwise low follow-through risk.

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC. (TRUP).

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUP CEO sold 491 shares in an open-market transaction at $21.86 on 2026-05-25, disclosed via SEC Form 4.

Expected impact

Likely limited, short-lived impact; any move would be more sentiment-driven than thesis-driven.

Evidence & confidence

The filing is an officer/director open-market sale with no 10b5-1 plan stated, but the article provides no accompanying company-specific catalyst (earnings, guidance, deal, or litigation).

Market effects

Minimal; this is company-specific insider activity without sector-wide information.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio management rather than a negative view, especially given the small share count relative to holdings.

Key entities

  • TRUPANION, INC.

    Company whose CEO reported an open-market sale of 491 shares via SEC Form 4.

  • Tooth Margaret

    CEO/officer/director who sold shares; filing includes post-transaction holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMedAI 8/10

Why is Trupanion (TRUP) stock soaring today

Trupanion (TRUP) shares rose 6.5% after reporting Q3 2026 revenue of $405.6M, up 10.5% YoY, and EPS of $0.21, both exceeding estimates. The company also reported strong cash flow and share repurchases. The stock has been volatile, with a 52-week low reached after a Q4 2025 EPS miss.

$TRUPHighAI 8/10

Trupanion Q3 Earnings Call Highlights

Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.

$TRUPMed

Trupanion Inc (TRUP) Q3 2026 Earnings Call Highlights: Record Adjusted Operating Income

Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.

$TRUPHigh

Trupanion Reports Third Quarter 2026 Results

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.